KEY ISSUES IN LIFE SCIENCES IP
LSIPR gathered a distinguished panel of experts from the IP legal profession to discuss issues such as the USPTO guidelines post Myriad/ Mayo, the future of blockbusters and the meaning of biosimilars.
Attendees
Paul Chapman Partner, Marks & Clerk
Anna Duch Senior associate, Cambridge IP
Paul England Senior associate, Taylor Wessing
Varuni Paranavitane Associate, Osborne Clarke
Chris Stothers Partner, Arnold & Porter
Jane Wainwright Partner, Potter Clarkson
Martin Essex Editor, LSIPR
Ed Conlon Deputy editor, LSIPR
News editor Max Walters
Editorial assistant David Brooke
Published by:
Newton Media Limited Kingfisher House, 21-23 Elmfield Road, Bromley, BR11LT,
United Kingdom +44 203 301 8200
Director Nicholas Lipinski
Publisher Peter Scott Telephone: +44 203 301 8217 Email:
pscott@newtonmedia.co.uk
Group editor Ed Conlon Telephone: +44 203 301 8210 Email:
econlon@newtonmedia.co.uk
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electrical, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher.
Sub-editor Ros Bromwich
Consultant John Haley
Production and design Fisherman Creative
©Newton Media Limited 2014
The views expressed in LSIPR are not necessarily those shared by the publisher, Newton Media Limited. Wishing to reflect the true nature of the market, we have included articles from a number of sources, and the views expressed are those of the individual contributors, not necessarily those of their respective businesses, and do not constitute legal advice. No responsibility or liability is accepted by Newton Media Limited for any loss to any person, legal or physical, as a result of any statement, fact or figure contained in LSIPR.
This publication is not a substitute for advice on a specific transaction. The publication of advertisements does not represent endorsement by the publisher.
Life Sciences IP Review (LSIPR): ISSN 2049-2359 (Print)
2
Life Sciences Intellectual Property Review Roundtable
www.lifesciencesipreview.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18